Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises FSN in acquisition of the Baggium Group
Mandate

Vinge advises FSN in acquisition of the Baggium Group

January 15, 2010

Vinge has advised funds managed by FSN Capital in connection with the acquisition of the Baggium Group. FSN Capital has offices in Oslo, Stockholm and Copenhagen and manages FSN Capitals’ funds. An independent team consisting of 17 Scandinavian investors is focusing on Nordic growth companies within the mid-cap segment which demonstrate organic or acquisition led growth potential.

FSN was advised by partners Fabian Ekeblad and Mikael Ståhl together with associates Paula Röttorp, Nils Taro Lock and Sofia Graflund. Competition law advice was provided by partner Pär Remnelid and associate Johanna Lindman.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025